Literature DB >> 1624608

Parathyroid hormone related protein in hypercalcaemia of Hodgkin's disease.

J Bolo-Deoku1, S Basu, S Lakhani, F Dunne, W A Ratcliffe, M Clarke, J L Barron.   

Abstract

The role of parathyroid hormone related protein (PTHRP) as a humoral mediator of hypercalcaemia was investigated in a patient with lymphocyte depleted Hodgkin's disease during an episode of hypercalcaemia, using an immunohistochemical staining technique for PTHRP on the tumour tissue and an immunoradiometric (IRMA) assay for PTHRP1-86 on the patient's plasma. The plasma PTHRP was less than 0.23 pmol/l in the range found in normocalcaemic controls, and the immunohistochemical staining was not positive for protein. PTHRP did not have a role in the pathogenesis of hypercalcaemia in this patient.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1624608      PMCID: PMC495236          DOI: 10.1136/jcp.45.6.541

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  Hodgkin's disease presenting with hypercalcaemia.

Authors:  R D Ellis; P R Beck; B K Mondal
Journal:  J Clin Pathol       Date:  1989-11       Impact factor: 3.411

2.  Recurrent hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in Hodgkin's disease.

Authors:  R J Mercier; J M Thompson; G S Harman; G L Messerschmidt
Journal:  Am J Med       Date:  1988-01       Impact factor: 4.965

3.  Hypercalcaemia in Hodgkin's disease without hyperparathyroidism or skeletal metastases.

Authors:  K M Mayne; C Bunch
Journal:  J Clin Pathol       Date:  1989-02       Impact factor: 3.411

4.  Hypercalcemia, Hodgkin's disease, and calcitriol.

Authors:  M A Needle; B Chandra
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

5.  Parathyroid hormone-related protein of malignancy: immunohistochemical and biochemical studies in normocalcaemic and hypercalcaemic patients with cancer.

Authors:  S H Ralston; J Danks; J Hayman; W D Fraser; C S Stewart; T J Martin
Journal:  J Clin Pathol       Date:  1991-06       Impact factor: 3.411

Review 6.  Humoral hypercalcemia in Hodgkin's disease. Clinical and laboratory evaluation.

Authors:  J O Jacobson; F R Bringhurst; N L Harris; S A Weitzman; A C Aisenberg
Journal:  Cancer       Date:  1989-03-01       Impact factor: 6.860

7.  Parathyroid hormone related protein and hypercalcaemia in breast cancer.

Authors:  N J Bundred; W A Ratcliffe; R A Walker; S Coley; J M Morrison; J G Ratcliffe
Journal:  BMJ       Date:  1991-12-14

8.  Parathyroid hormone-related protein: immunohistochemical localization in cancers and in normal skin.

Authors:  J A Danks; P R Ebeling; J Hayman; S T Chou; J M Moseley; J Dunlop; B E Kemp; T J Martin
Journal:  J Bone Miner Res       Date:  1989-04       Impact factor: 6.741

Review 9.  Hypercalcemia and vitamin D metabolism in Hodgkin's disease. Is there an underlying immunoregulatory relationship?

Authors:  J W Rieke; S S Donaldson; S J Horning
Journal:  Cancer       Date:  1989-05-01       Impact factor: 6.860

10.  Immunocytochemical demonstration of PTHrP protein in neoplastic tissue of HTLV-1 positive human adult T cell leukaemia/lymphoma: implications for the mechanism of hypercalcaemia.

Authors:  J M Moseley; J A Danks; V Grill; T A Lister; M A Horton
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

View more
  3 in total

1.  Nodular Lymphocyte Predominant Hodgkin's Lymphoma Presenting as Severe Hypercalcaemia: A Case Report.

Authors:  Ikram A Burney; V Nirmala; Mansour S Al-Moundhri; Nicholas J Woodhouse
Journal:  Sultan Qaboos Univ Med J       Date:  2007-12

2.  Parathyroid hormone related protein (PTHrP) in hypercalcaemia of lymphoproliferative disease.

Authors:  S V Davies; J Vora; C A Wardrop
Journal:  J Clin Pathol       Date:  1993-02       Impact factor: 3.411

3.  Hypercalcaemia in Hodgkin's disease related to prostaglandin synthesis.

Authors:  J B Laforga; J Vierna; F I Aranda
Journal:  J Clin Pathol       Date:  1994-06       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.